Ruori
Moderaattori:Jouni (katso kaikki)
Sivun edistymistä ei ole arvioitu. Arvostuksen määrää ei ole arvioitu (ks. peer review). |
Lisää dataa
|
Ruori on VN-TEAS-hanke, jossa arvioidaan erilaisia ruokaan liittyviä riskitekijöitä, niiden vähentämispotentiaalia ja niiden terveys- ja talousvaikutuksia.
Rajaus
Kysymys
Millaista tautitaakkaa Suomessa aiheuttavat Ruori-altisteet (tyydyttynyt rasva, vähäiset vihannekset, vähäiset hedelmät, liiallnen suola, dioksiinit, lyijy, toksoplasma, norovirus ja legionella?
Aikataulu ja käyttäjät
- Hanke alkoi 2018 ja loppuu 30.6.2019.
- Toteuttajina ovat Ruokavirasto, THL ja Helsingin yliopisto.
- Seuraavat skenaariot ovat tarkastelussa:
Vastaus
Vastaus kirjoitetaan tähän pian.
Perustelut
Data
Mitä kaikkea kuuluu vähäiseen hedelmien tai vihannesten syöntiin?
- Vähähedelmäinen ruokavalio: hedelmien kulutus alle 3 annosta päivässä (310 g yhteensä) (sisältää tuoreet, pakastetut, keitetyt, säilötyt ja kuivatut hedelmät mutta ei sisällä hedelmämehuja tai suolaan tai etikkaan säilöttyjä hedelmiä) http://www.healthdata.org/terms-defined. Diet low in fruits: Consumption of less than 3 servings (310 g total) of fruits per day (includes fresh, frozen, cooked, canned, or dried fruit but excludes fruit juices and salted or pickled fruits).
- Vähävihanneksinen ruokavalio: vihannesten kulutus alle 4 annosta (400 g yhteensä) (sisältää tuoreet, pakastetut, keitetyt, säilötyt ja kuivatut vihannekset mukaan lukien palkokasvit mutta ei sisällä suolaan tai etikkaan säilöttyjä vihanneksia eikä pähkinöitä, siemeniä tai tärkkelyspitoisia vihanneksia kuten perunaa tai maissia). Diet low in vegetables: Consumption of less than 4 servings (400 g total) of vegetables per day (includes fresh, frozen, cooked, canned, or dried vegetables including legumes but excluding salted or pickled, juices, nuts and seeds, and starchy vegetables such as potatoes or corn).
Luken tilastoista löytyy tietoja kalansyönnistä Suomessa. Järvikalaa ei ole eritelty, mutta muut kuin viljellyt ja merilajit ovat yhteensä 2.6 kg/a henkeä kohti. https://stat.luke.fi/en/fish-consumption-2017_en
Voiko DALYt muuntaa euroiksi, ja miten se tehdään?
- Drake ehdottaa globaalin arvon päättämistä DALYn hinnaksi, samaan tapaan kuin 1,25 dollarin alittava päivätulo on määritelty absoluuttiseksi köyhyydeksi. Tällöin kaikki tuota hintaa kustannustehokkaammat toimet kannattaisi tehdä joko kansallisin, tai jos se ei jostain syystä onnistu, kansainvälisin toimin. Hän ei kuitenkaan ehdota suuruutta tälle hinnalle.[1]
- Brent on analysoinut implisiittisiä hintoja DALYlle Global Fund for AIDS, Tuberculosis, and Malaria -säätiön rahoituspäätöksistä. DALYn hinta näyttää olevan 6300 USD kaikille taudeille keskimäärin, ja 11900 USD erityisesti HIV/AIDSille[2]. Globaalit luvut ovat toki pienemmät kuin mitä rikkaissa länsimaissa katsottaisiin aiheelliseksi käyttää.
- Erilaisista arvioinneista löytyy vaihtelevia lukuja yhden DALYn rahalliselle hinnalle. Esimerkiksi IOMin Shecan-projekti käytti arvoa 50393 €/menetetty elinvuosi[3], ja IGCB(N)-meluarviointiryhmä käyttää arvoa 60000 GBP/QALY (laatupainotettu elinvuosi) mutta samalla toteaa, että eri arvioinneissa arvot voivat vaihdella välillä 29000 - 130000 GBP/QALY[4][5].
- Berryn ja Flindellin mukaan Isossa-Britanniassa käytäntö on muodostunut sellaiseksi, että lääkkeet tai muut lääketieteelliset toimenpiteet saavat kansallisessa terveysjärjestelmässä helposti puollon, jos ne tuottavat yhden terveen elinvuoden alle 20000 GBP:n kustannuksilla. Tyypillisesti toteutetaan hankkeita tasolla 30000 GBP/QALY, mutta hankkeilta hinnaltaan yli 50000 GBP/QALY vaaditaan erityisiä perusteluja[6].
- Toisaalta Hammitt todistelee, että hinta per tilastollinen elämä (value per statistical life, VSL) ja hinta per DALY muuttuvat epälineaarisesti suhteessa toisiinsa, eikä näin ollen olisi mahdollista käyttää hyvinvointimuutoksen mittarina vakiolla kerrottua DALY-arvoa, ainakaan taloudellisen hyvinvointiteorian (economic welfare theory) puitteissa.[7]
Pitoisuusanalyysien kustannukset (poistettu).
Trikiinin valvontakustannukset: Tämän artikkelin mukaan trikiinin DALYt ovat vain luokkaa 100 DALY/miljardi ihmistä, joten valvonta ei ole mielekästä[8].
Malliparametrit
Obs | Response | Exposure_agent | Type | Subgroup | Unit | Result | Description |
---|---|---|---|---|---|---|---|
1 | CHD death | BoD | Age:Female 25-69 | DALY | 9876 (9103 - 10784) | Z:\Projects\RUORI\tautitaakka\Rasvat\IHD_data_IHME.csv | |
2 | CHD death | BoD | Age:Male 25-69 | DALY | 48851 (54035 - 46123) | Z:\Projects\RUORI\tautitaakka\Rasvat\IHD_data_IHME.csv | |
3 | CHD death | BoD | Age:Age 25-69 | DALY | 58727 (63138 - 56907) | Summed from previous | |
4 | CHD death | BoD | Age:Female 70+ | DALY | 42750 (41007 - 45909) | Z:\Projects\RUORI\tautitaakka\Rasvat\IHD_data_IHME.csv | |
5 | CHD death | BoD | Age:Male 70+ | DALY | 48150 (46327 - 51255) | Z:\Projects\RUORI\tautitaakka\Rasvat\IHD_data_IHME.csv | |
6 | CHD death | BoD | Age:Age 70+ | DALY | 90900 (87334 - 97164) | Summed from previous | |
7 | Diet high in sodium | BoD | Age:Total population | DALY | 1310 : 27670 : 66420 | IHME GBD2017. Triangular distribution used because normal would go below zero | |
8 | Diet low in fruits | BoD | Age:Total population | DALY | 36050 (20570 - 54800) | IHME GBD2017 http://ghdx.healthdata.org/gbd-results-tool?params=gbd-api-2017-permalink/da3bde44e863adb438c5fb47a89942fb | |
9 | Diet low in vegetables | BoD | Age:Total population | DALY | 28440 (14190 - 45960) | IHME GBD2017 | |
10 | Liver cancer | BoD | Age:Age 25-64 | DALY | 2499 (2018 - 3115) | From IHME (2014) | |
11 | Liver cancer | BoD | Age:Age 65-74 | DALY | 2745 (2245 - 3311) | From IHME (2014) | |
12 | dummy | case burden | Age:Female 25-69 | DALY /case | 0 | Needed for case_burden to cover all Ages | |
13 | dummy | case burden | Age:Female 70+ | DALY /case | 0 | Needed for case_burden to cover all Ages | |
14 | dummy | case burden | Age:Male 25-69 | DALY /case | 0 | Needed for case_burden to cover all Ages | |
15 | dummy | case burden | Age:Male 70+ | DALY /case | 0 | Needed for case_burden to cover all Ages | |
16 | dummy | case burden | Age:Age 25-64 | DALY /case | 0 | Needed for case_burden to cover all Ages | |
17 | dummy | case burden | Age:Age 65-74 | DALY /case | 0 | Needed for case_burden to cover all Ages | |
18 | IQ loss | case burden | Age:Age 1 | DALY /IQ | 0.11 (0.06 - 0.16) | Arja used 0.013 but here we use Goherr value instead | |
19 | Listeriosis | case burden | Age:Total population | DALY/case | 10 (5 - 13.3) | WHO 2015 report, European values (Table A8.2) | |
20 | Noro infection | case burden | Age:Total population | DALY/case | 0.0015 - 0.0025 | WHO 2015 report, European values (Table A8.2) | |
21 | Toxoplasmosis | case burden | Age:Age 0 (congenital) | DALY/case | 7 | WHO 2015 report, European values (Table A8.2) | |
22 | Toxoplasmosis | case burden | Age:Age 1+ (acquired) | DALY/case | 0.05 | WHO 2015 report, European values (Table A8.2) | |
23 | Cancer morbidity | case burden | Age:Female 18-45 | DALY/case | 0 - 0.28 | Goherr assessment | |
24 | Cancer morbidity | case burden | Age:Non female 18-45 | DALY/case | 0 - 0.28 | Goherr assessment | |
25 | Sperm concentration | case burden | Age:Female 18-45 | DALY/case | 0 - 2.5 | Goherr assessment | |
26 | Yes or no dental defect | case burden | Age:Female 18-45 | DALY/case | 0 - 0.12 | Goherr assessment | |
27 | Aflatoxin | exposure | Age:Age 25-64 | ng /kg /d | 0.85 - 1.14 | Finravinto 2012 | |
28 | Aflatoxin | exposure | Age:Age 65-74 | ng /kg /d | 0.5 - 0.67 | Finravinto 2012 | |
29 | TEQ | exposure | Exposure:To child; Age: Female 18-45 | pg /g | 1.65 (0.38 - 3.47) | Ruori code; data from Goherr assessment | |
30 | TEQ | exposure | Exposure:To eater; Age: Female 18-45 | pg /d | 4.79 (1.07 - 11.48) | Ruori code; data from Goherr assessment | |
31 | TEQ | exposure | Exposure:To child; Age: Non female 18-45 | pg /g | 7.92 (3.25 - 14.61) | Ruori code; data from Goherr assessment | |
32 | TEQ | exposure | Exposure:To eater; Age: Non female 18-45 | pg /d | 22.61 (9.43 - 44.75) | Ruori code; data from Goherr assessment | |
33 | Lead | exposure | Age:Age 1 | ug /l | 27.9 | Measured as blood concentration. RASKURI, Z:\Projects\RUORI\tautitaakka\Lyijy\Lyijy_tautitaakkadata.xlsx | |
34 | Saturated fat | exposure | Age:Age 25-69 | E% | 13.1 (12.9 - 13.4) | Finland, 2010 situation from Wang et al. Supplementary | |
35 | Saturated fat | exposure | Age:Age 70+ | E% | 13.2 (12.8 - 13.6) | Finland, 2010 situation from Wang et al. Supplementary | |
36 | Aflatoxin | frexposed | Age:Age 25-64 | fraction | 1 | dummy variable | |
37 | Aflatoxin | frexposed | Age:Age 65-74 | fraction | 1 | dummy variable | |
38 | Lead | frexposed | Age:Age 1 | fraction | 0.0657 | Population exposed to lead over threshold: 3126. RASKURI, Z:\Projects\RUORI\tautitaakka\Lyijy\Lyijy_tautitaakkadata.xlsx | |
39 | TEQ | frexposed | Age:Female 18-45 | fraction | 1 | frexposed is already in the exposure distribution | |
40 | TEQ | frexposed | Age:Non female 18-45 | fraction | 1 | frexposed is already in the exposure distribution | |
41 | IQ loss | incidence | Age:Age 1 | IQ /100000py | 596000 | On average, a population has ca. 6 IQ points per person below 100: mean(abs(rnorm(10000, 100,15)-100))/2 | |
42 | Listeriosis | incidence | Age:Total population | # /100000py | 1.22 | Tartuntatautirekisteri 2016: 66 kpl. WHO 2015 report, European values (Table A8.2): 0.2 (0.2 - 0.3) | |
43 | Liver cancer | incidence | Age:Age 25-64 | # /100000py | 4.06 | Finnish Cancer Registry, average 2011-2015 | |
44 | Liver cancer | incidence | Age:Age 65-74 | # /100000py | 26.16 | Finnish Cancer Registry, average 2011-2015 | |
45 | Noro infection | incidence | Age:Total population | # /100000py | 1652 (630 - 3294) | WHO 2015 report, European values (Table A8.2) | |
46 | Toxoplasmosis | incidence | Age:Age 0 (congenital) | # /100000py | 0.3 (0.2 - 0.7) | WHO 2015 report, European values (Table A8.2) | |
47 | Toxoplasmosis | incidence | Age:Age 1+ (acquired) | # /100000py | 119 (77 - 188) | WHO 2015 report, European values (Table A8.2) | |
48 | Cancer morbidity | incidence | Age:Female 18-45 | # /100000py | 657 | Statistics Finland https://tilastot.syoparekisteri.fi/syovat/ applies to all subgroups because cancer is lifetime risk | |
49 | Cancer morbidity | incidence | Age:Non female 18-45 | # /100000py | 657 | Statistics Finland https://tilastot.syoparekisteri.fi/syovat/ applies to all subgroups because cancer is lifetime risk | |
50 | Sperm concentration | incidence | Age:Female 18-45 | # /100000py | 700 | Male infertility rate is 7 % (Wikipedia). 10 % incidence of births | |
51 | Yes or no dental defect | incidence | Age:Female 18-45 | # /100000py | 2240 | Alaluusua et al 2004 found 11/49 cases in two lowest groups. 10 % incidence of births | |
52 | Diet low in fruits | Fruits | PAF | Age:Total population | fraction | 1 | dummy variable |
53 | Listeriosis | Listeria | PAF | Age:Total population | fraction | 1 | dummy variable |
54 | Noro infection | Noro virus | PAF | Age:Total population | fraction | 1 | dummy variable |
55 | CHD death | Saturated fat | PAF | Age:Age 25-69 | fraction | 0.064 (0.050 - 0.078) | Finland, 2010 situation from Wang et al. Supplementary |
56 | CHD death | Saturated fat | PAF | Age:Age 70+ | fraction | 0.048 (0.033 - 0.063) | Finland, 2010 situation from Wang et al. Supplementary |
57 | Diet high in sodium | Sodium | PAF | Age:Total population | fraction | 1 | dummy variable |
58 | Toxoplasmosis | Toxoplasma gondii | PAF | Age:Age 0 (congenital) | fraction | 1 | dummy variable |
59 | Toxoplasmosis | Toxoplasma gondii | PAF | Age:Age 1+ (acquired) | fraction | 1 | dummy variable |
60 | Diet low in vegetables | Vegetables | PAF | Age:Total population | fraction | 1 | dummy variable |
61 | population | Age:Age 1 | 50934 | Statistics Finland, 2018 https://pxnet2.stat.fi:443/PXWeb/sq/ac3373d0-e303-4c67-b32a-73c6d26df809 | |||
62 | population | Age:Age 25-64 | # | 2814305 | Statistics Finland | ||
63 | population | Age:Age 65-74 | # | 692868 | Statistics Finland | ||
64 | population | Age:Age 25-69 | # | 3176513 | Statistics Finland | ||
65 | population | Age:Age 70+ | # | 842629 | Statistics Finland | ||
66 | population | Age:Total population | # | 5517919 | Statistics Finland | ||
67 | population | Age:Age 0 (congenital) | # | 47663 | Statistics Finland | ||
68 | population | Age:Age 1+ (acquired) | # | 5470256 | Statistics Finland | ||
69 | population | Age:Female 18-45 | # | 923697 | Statistics Finland | ||
70 | population | Age:Non female 18-45 | # | 4594222 | Statistics Finland | ||
71 | Hepatitis | prevalence | Hepatitis:Hepatitis B- | fraction | 0.005 | TerveSuomi | |
72 | Hepatitis | prevalence | Hepatitis:Hepatitis B+ | fraction | 0.995 | TerveSuomi | |
73 | Saturated fat | scenario exposure | Age:Male 18-24 | E% | 14.9 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
74 | Saturated fat | scenario exposure | Age:Male 25-44 | E% | 15.2 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
75 | Saturated fat | scenario exposure | Age:Male 45-64 | E% | 15.3 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
76 | Saturated fat | scenario exposure | Age:Male 65-74 | E% | 14.4 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
77 | Saturated fat | scenario exposure | Age:Female 18-24 | E% | 13.8 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
78 | Saturated fat | scenario exposure | Age:Female 25-44 | E% | 14.8 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
79 | Saturated fat | scenario exposure | Age:Female 45-64 | E% | 14.3 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
80 | Saturated fat | scenario exposure | Age:Female 65-74 | E% | 14.0 | Finravinto 2017. Supplementary table 7.12. Average daily intake of saturated fats by gender and age. | |
81 | IQ loss | Lead | threshold | Age:Age 1 | ug /l | 24 | Lanphear et al 2005 https://doi.org/10.1289/ehp.7688 CHECK THRESHOLD |
82 | Liver cancer | Aflatoxin | UR | Hepatitis:Hepatitis B- | # /(ng /kg /d /100000py) | 0.01 (0.002 - 0.03) | WHO Is this per year or per lifetime? |
83 | Liver cancer | Aflatoxin | UR | Hepatitis:Hepatitis B+ | # /(ng /kg /d /100000py) | 0.3 (0.01 - 0.5) | WHO Is this per year or per lifetime? |
84 | IQ loss | Lead | UR | Age:Age 1 | IQ l /ug | 0.039 | Lanphear et al 2005 https://doi.org/10.1289/ehp.7688 CHECK THRESHOLD |
85 | Sodium | reduction | Age:Total population | g /d | 0.471 - 0.729 | RUORI estimates 3.3-5.1 g/week reduction for workplace lunches with heart-friendly label | |
86 | Sodium | intake | Age:Total population | g /d | 6.4 - 8.7 | Valsta 2018 estimated the lower value for females and upper for males. | |
87 | Sodium | recommendation | Age:Total population | g /d | 5 | Finnish recommendation by Ruokavirasto | |
88 | Sodium | eaters | Age:Total population | # | 279000 | RUORI estimate based on Taloustutkimus 2010 | |
89 | Saturated fat | reduction | Age:Age 25-69 | E% | 1.397 - 3.689 | RUORI estimates 22.0 - 58.1 g /week, and on average 2.25 g /d /E% | |
90 | Saturated fat | intake | Age:Age 25-69 | E% | 14 - 15 | Valsta 2018 estimated the lower value for females and upper for males. | |
91 | Saturated fat | recommendation | Age:Age 25-69 | E% | 10 | Recommendation by Ruokavirasto? | |
92 | Saturated fat | eaters | Age:Age 25-69 | # | 279000 | RUORI estimate based on Taloustutkimus 2010 | |
93 | Vegetables | reduction | Age:Total population | g /d | -30 - 0 | RUORI estimates that the consumption increases by 0-14% (up to the % change of tax reduction) i.e. 0.14*213. | |
94 | Vegetables | intake | Age:Total population | g /d | 196 - 213 | Valsta 2018 estimated the lower value for males and upper for females. (vegetables, legumes, nuts) | |
95 | Vegetables | recommendation | Age:Total population | g /d | 400 | Recommendation by IHME | |
96 | Vegetables | eaters | Age:Total population | # | 5470256 | RUORI estimate based on Taloustutkimus 2010 | |
97 | Fruits | reduction | Age:Total population | g /d | -26 - 0 | RUORI estimates that the consumption increases by 0-14% (up to the % change of tax reduction) i.e. 0.14*189. | |
98 | Fruits | intake | Age:Total population | g /d | 135 - 189 | Valsta 2018 estimated the lower value for males and upper for females. (fruits and berries) | |
99 | Fruits | recommendation | Age:Total population | g /d | 310 | Recommendation by IHME | |
100 | Fruits | eaters | Age:Total population | # | 5470256 | RUORI estimate based on Taloustutkimus 2010 |
Annos-vasteet on tässä vain näytillä, ja oikeat käyttöön tulevat luvut ovat sivulla op_en:ERFs of environmental pollutants.
Obs | Decision | Option | Variable | Cell | Change | Result | Description |
---|---|---|---|---|---|---|---|
1 | Adjust | BAU | incidence | Multiply | 0.00001 | 1/100000 py --> 1 py | |
2 | Adjust | BAU | PAF | Exposure_agent:Saturated fat | Multiply | 1.132 | Scaled from Wang to Finravinto 2017: mean(15.2,15.3,14.8,14.0)/13.1 |
3 | Hepatitis | Hepatitis B- | BoD | Multiply | 0.995 | Healthy people. Data from TerveSuomi | |
4 | Hepatitis | Hepatitis B+ | BoD | Multiply | 0.005 | Hepatitis B patients. Data from TerveSuomi | |
5 | Adjust | BAU | ERF | Response:Liver cancer | Multiply | 0.00001 | 1/100000py --> 1/py |
6 | Scenario | Action | PAF | Exposure_agent:Saturated fat | Multiply | 0.911 : 0.944 : 0.971 | Based on RUORI modelling (see code) |
7 | Scenario | Action | PAF | Exposure_agent:Sodium | Multiply | 0.975 : 0.990 : 0.993 | Based on RUORI modelling (see code) |
8 | Scenario | BAU | PAF | Identity | For completion | ||
9 | Scenario | Action | PAF | Response:Toxoplasmosis;Age:Age 0 (congenital) | Multiply | 0 | Complete testing and treatment of gongenital disease |
10 | Scenario | Action | PAF | Response:Listeriosis | Multiply | 0 | Complete testing and removal of pathogen |
11 | Scenario | Action | exposure | Exposure_agent:Aflatoxin | Multiply | 0.95-1 | 0-5% reduction of exposure based on 10 % more testing |
12 | Scenario | Action | exposure | Exposure_agent:Lead | Multiply | 0.963-0.975 | 2.5-3.7% reduction of exposure based on more testing |
13 | Scenario | BAU | exposure | Identity | For completion | ||
14 | Scenario | Action | PAF | Exposure_agent:Noro virus | Multiply | 0.65 : 1 : 1 | 35 % are from food industry so that is the max reduction from testing |
15 | Scenario | Action | PAF | Exposure_agent:Vegetables | Multiply | 0.85 - 1 | Based on RUORI modelling (see code) |
16 | Scenario | Action | PAF | Exposure_agent:Fruits | Multiply | 0.82 - 1 | Based on RUORI modelling (see code) |
17 | Adjust | BAU | exposure | Add | 0.01 | Roughly 98 % of all exposures for Exposure_agents is > 0.005. This prevents NaN in log scaling. | |
18 | Scenario | Action | exposure | Exposure: To child; Age: Female 18-45 | Replace | 0.98 (0.17 - 2.9) | Based on RUORI modelling (see code) |
19 | Scenario | Action | exposure | Exposure: To eater; Age: Female 18-45 | Replace | 2.79 (0.56 - 7.08) | Based on RUORI modelling (see code) |
20 | Scenario | Action | exposure | Exposure: To child; Age: Non female 18-45 | Replace | 3.68 (1.16 - 11.27) | Based on RUORI modelling (see code) |
21 | Scenario | Action | exposure | Exposure: To eater; Age: Non female 18-45 | Replace | 11.38 (3.44 - 46.22) | Based on RUORI modelling (see code) |
Obs | Variable | Index | Probs | Function | Dummy | Description |
---|---|---|---|---|---|---|
1 | BoD | incidenceSource,disabilityweightSource,populationSource,BoDSource | sum | 1 | Remove redundant | |
2 | PAF | Unit, Exposure, Scaling,Exposcen, ER_function, ERFchoiceSource, exposureSource, bgexposureSource, BWSource, doseSource, thresholdSource, ERFSource, RRSource, frexposedSource, incidenceSource, InpPAFSource | sum | 1 | Remove redundant | |
3 | case_burden | case_burdenSource | sum | 1 | Fill missing Ages | |
4 | BoDattr | PAFSource, Hepatitis, Adjust | sum | 1 | Remove redundant | |
5 | amount | assumpSource, oftenSource, muchSource, oftensideSource, muchsideSource, amountRawSource, effinfoSource, effrecommSource, amountSource | sum | 1 | Remove redundant | |
6 | expo_indir | f_ingSource, t0.5Source,f_mtocSource, BFSource | sum | 1 | Remove redundant | |
7 | dose | Source, concSource, expo_dirSrouce, exposureSource, BWSource, Source.1 | sum | 1 | Remove redundant | |
8 | conc | Fish | 0, 1, 0, 0, 0, 0, 0.19, 0.19, 0.19, 0, 0, 0, 0, 0, 0, 0, 0.29, 0.14 | sample | 1 | Probs relative to consumption; Baltic herring has equal weight with others combined because it is another scenario. Arctic char, Baltic herring, Bream, Burbot, Cod, Flounder, Perch, Pike, Pike-perch, Rainbow trout, River lamprey, Roach, Salmon, Sea trout, Sprat, Trout, Vendace, Whitefish |
9 | ERF | Exposure, Age | sum | 1 | Remove redundant | |
10 | threshold | Exposure, Age | sum | 1 | Remove redundant |
Laskenta
Arviointimalli
Skenaariot
Tyydyttyneen rasvan ja suolan osalta tarkastellaan sydänmerkkiaterioita. Oletetaan, että kaikki lounasruokaloiden ateriat muuttuvat sydänmerkkiaterioiksi. Väestön suuruudeksi oletetaan nykyinen lounaspaikkaruokailijoiden päivittäinen määrä eli 279000, ja heille oletetaan pysyvä muutos ruokavalioon.
Kun ei murehdita altistusjakaumasta, voidaan keskimääräisestä saannista vähentää vähennys, ja tämä muutos kohdennetaan vain 25-69-vuotiaaseen alaryhmään (jos alaryhmä on kyseiselle vasteelle määritelty). Skenaariossa kerrotaan PAF luvulla, joka saa arvon 1 nykyisellä altistuksella ja arvon 0 suosituksen mukaisella arvolla. Tätäitä laimennetaan altistujien osuudella. Niinpä käytetään tätä kaavaa kertoimen laskemiseksi:
PAF_factor = 1-(reduction / (intake-recommendation)) * eaters / population
Suola:
Sydänmerkki vähensi 2016 suolan saantia 1 g/d eli 4.2-5.2 g/vk eli 10 %. Tässä oletetaan 3.3-5.1 g/vk vähennys eli 0.471 - 0.729 g/d myös viikoloput huomioiden. Jula (2011) arvioi, että 1 g/d vähennys koko väestössä alentaa kustannuksia 70 Me/a. (Tarkista onko tautitaakkaa!)
Suositus on enintään 5 g/d. Nykysaanti (Valsta 2018) on miehillä 8.7 g/d ja naisilla 6.4 g/d ja tätä käytetään tasajakaumana koko väestölle, koska sukupuolia ei tarkastella erikseen.
Rasva:
Sydänmerkkiateria vähensi saantia 14 E%:sta 10 E%:iin. Tässä oletetaan, että vähennys on 22.0-58.1 g/vk.
Suositus on enintään 10 E%.
Valsta (2018): Tyydyttyneiden rasvahappojen osuus kokonaisenergiasta oli naisilla 14 % (28 g/vrk) ja miehillä 15 % (38 g/vrk). Naisilla muuntosuhde on 2 g /d /E% ja miehillä 2.53 g /d /E%, käytetään 2.25 g /d /E%. Grammamääräinen altistus on muutettava energiaosuudeksi.
22.0-58.1 g/vk / (7d/vk) / (2.25 g /d /E%) = 1.397 - 3.689 E%
Näiden tietojen avulla lasketaan PAF-kertoimen jakauma, joka sijoitetaan päätöstauluun päätöksenä Scenario ja vaihtoehtona Action.
- Malliajo 29.5.2019 [3]
- Malliajo 31.5.2019 [4]
- Malliajo 4.6.2019, ovariablet haetaan ao. sivuilta ja OpasnetUtilsista on päivitetty versio (ei toimi vanhalla) [5]
- Malliajo 12.6.2017 jossa suolan ja rasvan skenaario [6]
- Malliajo 12.6. myös muita skenaarioita [7]
- Malliajo 13.6.2019 skenaariot dioksiinia lukuunottamatta [8]
- Malliajo 16.6.2019 melkein toimii [9]
Dioksiiniskenaario
Tautitaakkakuvia
Viitteet
- ↑ Drake T. (2014) Priority setting in global health: towards a minimum DALY value. Health Economics Letter 23:2:248-252. https://doi.org/10.1002/hec.2925
- ↑ Brent RJ. (2011) An implicit price of a DALY for use in a cost-benefit analysis of ARVs. Applied Economics 43:11:1413-1421. https://doi.org/10.1080/00036840802600475
- ↑ Minstry R. (2011) Methodology for valuing health impacts on the SHEcan project. IOM Research Project P937/96. http://ec.europa.eu/social/BlobServlet?docId=10178&langId=en
- ↑ The Interdepartmental Group on Costs and Benefits Noise Subject Group. (2014) Environmental Noise: Valuing impacts on sleep disturbance, annoyance, hypertension, productivity and quiet. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/380852/environmental-noise-valuing-imapcts-PB14227.pdf
- ↑ The Interdepartmental Group on Costs and Benefits Noise Subject Group (IGCB(N)). (2010) Noise & Health – Valuing the Human Health Impacts of Environmental Noise Exposure. https://khub.net/c/document_library/get_file?uuid=6a229977-e27a-43c5-a780-e224649bd2df&groupId=6197021
- ↑ Berry BF, Flindell IH. (2009) Estimating Dose-Response Relationships between Noise Exposure and Human Health Impacts in the UK. BEL Technical Report 2009-002. https://webarchive.nationalarchives.gov.uk/20130123222353/http://archive.defra.gov.uk/environment/quality/noise/igcb/documents/tech-report.pdf
- ↑ Hammitt, J.K. (2013) Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures. J Risk Uncertain 47: 311. https://doi.org/10.1007/s11166-013-9178-4
- ↑ Brecht Devleesschauwer, Nicolas Praet, Niko Speybroeck, Paul R. Torgerson, Juanita A. Haagsma, KrisDe Smet, K. Darwin Murrell, Edoardo Pozio, Pierre Dorny. (2015) The low global burden of trichinellosis: evidence and implications. International Journal for Parasitology 45, 2–3, 95-99. [1] [2]